Tag: pharmaceuticals
-

Health Research Commercialization Company Launched
University of Michigan and health care investor Deerfield Management are creating a new enterprise to bring promising academic life science research to market.
-

Antibody Drug Biotech Raises $105M in Venture Funds
A company that says it has a faster process for discovering therapeutic antibodies is raising $105 million in its second venture finance round.
-

Merck Inks Three Covid-19 Vaccine, Therapy Deals
Drug maker Merck today gained a new acquisition, along with collaboration and licensing deals, for vaccines and a therapy for Covid-19 infections.
-

Covid-19 Therapies Designed with Virtual Reality, A.I.
Two companies are using deep learning and virtual reality to design treatments for Covid-19 infections, attacking a different target than most drugs being developed.
-

Covid-19 Vaccine Produces Antibodies in Preclinical Test
Tests with lab animals show a Covid-19 vaccine now in clinical trials produces neutralizing antibodies to prevent coronavirus infections.
-

Antibody Neutralizes Covid-19, SARS Viruses
An academic-industry team discovered that an antibody produced during the 2003 SARS outbreak can neutralize similar viruses causing Covid-19 infections.
-

Covid-19 Vaccine Generates Immune Response
First results from a clinical trial testing a vaccine to protect against Covid-19 infections show the vaccine produces an immune response in healthy participants.
-

Infographic – Vaccines Stop Infectious Diseases
One of the reasons so much depends on a vaccine is due to their track record in preventing the spread of infectious diseases, and almost completely eradicating the disease in many cases.
-

Covid-19 Lung Disease Trial Adds Treatments
A clinical trial testing treatments for lung damage in severe Covid-19 cases is adding the anti-viral drug remdesivir and convalescent plasma to its protocol.
-

FDA Issues Covid-19 Therapy Trials, Review Guidance
The Food and Drug Administration issued new regulatory guidance on clinical trials and streamlined review processes for Covid-19 treatments.